ATE380820T1 - Murine alpha(1,3)-fucosyltransferase (fuc-tvii) - Google Patents

Murine alpha(1,3)-fucosyltransferase (fuc-tvii)

Info

Publication number
ATE380820T1
ATE380820T1 AT97908788T AT97908788T ATE380820T1 AT E380820 T1 ATE380820 T1 AT E380820T1 AT 97908788 T AT97908788 T AT 97908788T AT 97908788 T AT97908788 T AT 97908788T AT E380820 T1 ATE380820 T1 AT E380820T1
Authority
AT
Austria
Prior art keywords
fucosyltransferase
tvii
fuc
murine alpha
murine
Prior art date
Application number
AT97908788T
Other languages
English (en)
Inventor
Shunji Natsuka
Kevin Gersten
John Lowe
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE380820T1 publication Critical patent/ATE380820T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97908788T 1996-03-08 1997-03-07 Murine alpha(1,3)-fucosyltransferase (fuc-tvii) ATE380820T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61309896A 1996-03-08 1996-03-08

Publications (1)

Publication Number Publication Date
ATE380820T1 true ATE380820T1 (de) 2007-12-15

Family

ID=24455853

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908788T ATE380820T1 (de) 1996-03-08 1997-03-07 Murine alpha(1,3)-fucosyltransferase (fuc-tvii)

Country Status (7)

Country Link
US (2) US6693183B2 (de)
EP (1) EP0888377B1 (de)
JP (1) JP2000507095A (de)
AT (1) ATE380820T1 (de)
AU (1) AU731261B2 (de)
DE (1) DE69738368T2 (de)
WO (1) WO1997032889A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
US6060295A (en) * 1998-01-29 2000-05-09 The Board Of Regents Of The University Of Oklahoma Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases
US6071732A (en) * 1998-01-29 2000-06-06 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof
US6713283B2 (en) 1998-01-29 2004-03-30 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases
US6605455B1 (en) 1998-01-29 2003-08-12 The Board Of Regsnts Of The University Of Oklahoma Tyrosylprotein sulfotransferases and methods of use thereof
US6204016B1 (en) 1998-01-29 2001-03-20 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases and methods of use thereof
US7029890B2 (en) 1998-01-29 2006-04-18 Siwa Biotech Corporation Tyrosylprotein sulfotransferases and methods of use thereof
US6207432B1 (en) 1998-01-29 2001-03-27 The Board Of Regents Of The University Of Oklahoma Tyrosylprotein sulfotransferases and methods of use thereof
WO1999048926A1 (fr) * 1998-03-24 1999-09-30 Kyowa Hakko Kogyo Co., Ltd. ANTICORPS DIRIGE CONTRE LA α1,3-FUCOSYLTRANSFERASE (Fuc-TVII) HUMAINE
JP2004528001A (ja) * 2000-05-12 2004-09-16 ネオーズ テクノロジーズ， インコーポレイテッド インビトロにおけるフコシル化組換えグリコペプチド
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7173003B2 (en) * 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
DE60336555D1 (de) * 2002-06-21 2011-05-12 Novo Nordisk Healthcare Ag Pegylierte glykoformen von faktor vii
NZ542094A (en) * 2003-03-14 2008-12-24 Neose Technologies Inc Branched polymer conjugates comprising a peptide and water-soluble polymer chains
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
JP2007523630A (ja) * 2003-05-09 2007-08-23 ネオス テクノロジーズ インコーポレイテッド ヒト成長ホルモングリコシル化突然変異体の組成と調合法
US9005625B2 (en) * 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) * 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
CN1897812B (zh) * 2003-12-03 2011-08-17 生物种属学股份公司 糖聚乙二醇化的粒细胞集落刺激因子
NZ548123A (en) * 2004-01-08 2010-05-28 Novo Nordisk As O-linked glycosylation of peptides
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
US20090292110A1 (en) * 2004-07-23 2009-11-26 Defrees Shawn Enzymatic modification of glycopeptides
WO2006031811A2 (en) * 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
WO2006050247A2 (en) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodeling and glycopegylation of fibroblast growth factor (fgf)
US9029331B2 (en) * 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20110003744A1 (en) * 2005-05-25 2011-01-06 Novo Nordisk A/S Glycopegylated Erythropoietin Formulations
EP2975135A1 (de) 2005-05-25 2016-01-20 Novo Nordisk A/S Glykopegylierter Faktor IX
FI20055398A0 (fi) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP2049144B8 (de) * 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylierung von peptiden über o-verbundene glycosylierungssequenzen
EP2054521A4 (de) * 2006-10-03 2012-12-19 Novo Nordisk As Verfahren zur reinigung von polypeptid-konjugate
ES2655734T3 (es) * 2006-10-04 2018-02-21 Novo Nordisk A/S Glicopéptidos y azúcares pegilados unidos a glicerol
HRP20130382T1 (hr) * 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
WO2008151258A2 (en) * 2007-06-04 2008-12-11 Neose Technologies, Inc. O-linked glycosylation using n-acetylglucosaminyl transferases
CA2690611C (en) * 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
US8207112B2 (en) * 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
CA2711503A1 (en) * 2008-01-08 2009-07-16 Biogenerix Ag Glycoconjugation of polypeptides using oligosaccharyltransferases
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
EP2166085A1 (de) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalente modifizierte Zellen
WO2011011500A1 (en) * 2009-07-21 2011-01-27 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
WO2011011477A1 (en) * 2009-07-21 2011-01-27 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
US9692789B2 (en) 2013-12-13 2017-06-27 Oracle International Corporation Techniques for cloud security monitoring and threat intelligence
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3756946B2 (ja) * 1993-03-29 2006-03-22 協和醗酵工業株式会社 α１，３−フコシルトランスフェラーゼ
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
US5858750A (en) * 1997-11-25 1999-01-12 Incyte Pharmaceuticals, Inc. Human retinol dehydrogenase type II homolog

Also Published As

Publication number Publication date
AU731261B2 (en) 2001-03-29
EP0888377A1 (de) 1999-01-07
JP2000507095A (ja) 2000-06-13
WO1997032889A1 (en) 1997-09-12
US20040063178A1 (en) 2004-04-01
AU2060897A (en) 1997-09-22
EP0888377B1 (de) 2007-12-12
DE69738368D1 (de) 2008-01-24
US6693183B2 (en) 2004-02-17
US7723080B2 (en) 2010-05-25
US20020111469A1 (en) 2002-08-15
DE69738368T2 (de) 2008-12-04
EP0888377A4 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
ATE380820T1 (de) Murine alpha(1,3)-fucosyltransferase (fuc-tvii)
HUP0202759A2 (hu) Táptalaj sejtek fehérjementes és szérummentes tenyésztéséhez
CA2167521A1 (en) Compositions and methods for producing sialyltransferases
DK0960109T3 (da) Fremgangsmåde til fremstilling af tolterodin
AP9400666A0 (en) Benzofuran derivatives.
AU6226198A (en) Improved methods of making cross-bridged macropolycycles
NO943323D0 (no) Sammensetninger og fremgangsmåte for identifisering og syntese av sialyltransferaser
BG102016A (en) Method for the diagnostics of schizophrenia
MY110619A (en) Ring-substituted 2-amino-1, 2,3, 4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes.
AU4823993A (en) Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof
EP0733709A3 (de) Mutierte Farnesyldiphosphatesynthase befähigt zum Synthetisieren von Geranylgeranyldiphosphat und dafür kodierende Gene
CY1116418T1 (el) Διεργασια για την παραγωγη r-(+)-6-καρβοξαμιδο-3-ν-μεθυλαμινο-1,2,3,4-τετραϋδροκαρβαζολιου
BG108682A (en) Method for the production of transparent flexible container, and container produced therewith
MY106522A (en) Arylaminocarbonyl compounds.
MY131172A (en) 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd) indoles
EP1082126A4 (de) Neue peptide
AU1170501A (en) Cubic boron nitride clusters
IL139773A0 (en) Morphine-6-glucuronide synthesis
GB2341391B (en) Cloning of UDP-galactose epimerase
IT1303824B1 (it) Procedimento per la produzione di caprolattame di elevata purezza.
GB2325466A (en) Nucleotide sequence from goat liver
DE69637429D1 (de) Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
CA2247966A1 (en) Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof
AU2455600A (en) Apoptosis-inducing factor
AU5369399A (en) Basic refractory ceramic hollow body

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties